{"nct_id":"NCT00364611","title":"Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2012-04","start_date":"2006-08","start_date_type":null,"primary_completion_date":"2011-06","primary_completion_date_type":"ACTUAL","completion_date":"2012-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}